<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Optimal phase II/III drug development planning for multi-arm programs with binary endpoint — optimal_multiarm_binary • drugdevelopR</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Optimal phase II/III drug development planning for multi-arm programs with binary endpoint — optimal_multiarm_binary"><meta name="description" content="The optimal_multiarm_binary function enables planning of
multi-arm phase II/III drug
development programs with optimal sample size allocation and go/no-go
decision rules. For binary endpoints the treatment effect is measured by the
risk ratio (RR). So far, only three-arm trials with two treatments and one
control are supported. The assumed true treatment effects can be assumed fixed
or modelled by a prior distribution. The R Shiny application
prior visualizes the prior
distributions used in this package. Fast computing is enabled by parallel
programming."><meta property="og:description" content="The optimal_multiarm_binary function enables planning of
multi-arm phase II/III drug
development programs with optimal sample size allocation and go/no-go
decision rules. For binary endpoints the treatment effect is measured by the
risk ratio (RR). So far, only three-arm trials with two treatments and one
control are supported. The assumed true treatment effects can be assumed fixed
or modelled by a prior distribution. The R Shiny application
prior visualizes the prior
distributions used in this package. Fast computing is enabled by parallel
programming."></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">drugdevelopR</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">1.0.2</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/Introduction-to-drugdevelopR.html">Introduction to planning phase II and phase III trials with drugdevelopR</a></li>
    <li><a class="dropdown-item" href="../articles/Package_validation.html">Package validation</a></li>
    <li><hr class="dropdown-divider"></li>
    <li><a class="dropdown-item" href="../articles/index.html">More articles...</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/Sterniii3/drugdevelopR/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Optimal phase II/III drug development planning for multi-arm programs with binary endpoint</h1>
      <small class="dont-index">Source: <a href="https://github.com/Sterniii3/drugdevelopR/blob/HEAD/R/optimal_multiarm_binary.R" class="external-link"><code>R/optimal_multiarm_binary.R</code></a></small>
      <div class="d-none name"><code>optimal_multiarm_binary.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The <code>optimal_multiarm_binary</code> function enables planning of
multi-arm phase II/III drug
development programs with optimal sample size allocation and go/no-go
decision rules. For binary endpoints the treatment effect is measured by the
risk ratio (RR). So far, only three-arm trials with two treatments and one
control are supported. The assumed true treatment effects can be assumed fixed
or modelled by a prior distribution. The R Shiny application
<a href="https://web.imbi.uni-heidelberg.de/prior/" class="external-link">prior</a> visualizes the prior
distributions used in this package. Fast computing is enabled by parallel
programming.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">optimal_multiarm_binary</span><span class="op">(</span></span>
<span>  <span class="va">p0</span>,</span>
<span>  <span class="va">p11</span>,</span>
<span>  <span class="va">p12</span>,</span>
<span>  <span class="va">n2min</span>,</span>
<span>  <span class="va">n2max</span>,</span>
<span>  <span class="va">stepn2</span>,</span>
<span>  <span class="va">rrgomin</span>,</span>
<span>  <span class="va">rrgomax</span>,</span>
<span>  <span class="va">steprrgo</span>,</span>
<span>  <span class="va">alpha</span>,</span>
<span>  <span class="va">beta</span>,</span>
<span>  <span class="va">c2</span>,</span>
<span>  <span class="va">c3</span>,</span>
<span>  <span class="va">c02</span>,</span>
<span>  <span class="va">c03</span>,</span>
<span>  K <span class="op">=</span> <span class="cn">Inf</span>,</span>
<span>  N <span class="op">=</span> <span class="cn">Inf</span>,</span>
<span>  S <span class="op">=</span> <span class="op">-</span><span class="cn">Inf</span>,</span>
<span>  steps1 <span class="op">=</span> <span class="fl">1</span>,</span>
<span>  stepm1 <span class="op">=</span> <span class="fl">0.95</span>,</span>
<span>  stepl1 <span class="op">=</span> <span class="fl">0.85</span>,</span>
<span>  <span class="va">b1</span>,</span>
<span>  <span class="va">b2</span>,</span>
<span>  <span class="va">b3</span>,</span>
<span>  <span class="va">strategy</span>,</span>
<span>  num_cl <span class="op">=</span> <span class="fl">1</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-p-">p0<a class="anchor" aria-label="anchor" href="#arg-p-"></a></dt>
<dd><p>assumed true rate of the control group</p></dd>


<dt id="arg-p-">p11<a class="anchor" aria-label="anchor" href="#arg-p-"></a></dt>
<dd><p>assumed true rate of the treatment arm 1</p></dd>


<dt id="arg-p-">p12<a class="anchor" aria-label="anchor" href="#arg-p-"></a></dt>
<dd><p>assumed true rate of treatment arm 2</p></dd>


<dt id="arg-n-min">n2min<a class="anchor" aria-label="anchor" href="#arg-n-min"></a></dt>
<dd><p>minimal total sample size in phase II, must be divisible by 3</p></dd>


<dt id="arg-n-max">n2max<a class="anchor" aria-label="anchor" href="#arg-n-max"></a></dt>
<dd><p>maximal total sample size in phase II, must be divisible by 3</p></dd>


<dt id="arg-stepn-">stepn2<a class="anchor" aria-label="anchor" href="#arg-stepn-"></a></dt>
<dd><p>stepsize for the optimization over n2, must be divisible by 3</p></dd>


<dt id="arg-rrgomin">rrgomin<a class="anchor" aria-label="anchor" href="#arg-rrgomin"></a></dt>
<dd><p>minimal threshold value for the go/no-go decision rule</p></dd>


<dt id="arg-rrgomax">rrgomax<a class="anchor" aria-label="anchor" href="#arg-rrgomax"></a></dt>
<dd><p>maximal threshold value for the go/no-go decision rule</p></dd>


<dt id="arg-steprrgo">steprrgo<a class="anchor" aria-label="anchor" href="#arg-steprrgo"></a></dt>
<dd><p>step size for the optimization over RRgo</p></dd>


<dt id="arg-alpha">alpha<a class="anchor" aria-label="anchor" href="#arg-alpha"></a></dt>
<dd><p>one-sided significance level/family-wise error rate</p></dd>


<dt id="arg-beta">beta<a class="anchor" aria-label="anchor" href="#arg-beta"></a></dt>
<dd><p>type-II error rate for any pair, i.e. <code>1 - beta</code> is the (any-pair) power for calculation of the sample size for phase III</p></dd>


<dt id="arg-c-">c2<a class="anchor" aria-label="anchor" href="#arg-c-"></a></dt>
<dd><p>variable per-patient cost for phase II</p></dd>


<dt id="arg-c-">c3<a class="anchor" aria-label="anchor" href="#arg-c-"></a></dt>
<dd><p>variable per-patient cost for phase III</p></dd>


<dt id="arg-c-">c02<a class="anchor" aria-label="anchor" href="#arg-c-"></a></dt>
<dd><p>fixed cost for phase II</p></dd>


<dt id="arg-c-">c03<a class="anchor" aria-label="anchor" href="#arg-c-"></a></dt>
<dd><p>fixed cost for phase III</p></dd>


<dt id="arg-k">K<a class="anchor" aria-label="anchor" href="#arg-k"></a></dt>
<dd><p>constraint on the costs of the program, default: <code>Inf</code>, e.g. no constraint</p></dd>


<dt id="arg-n">N<a class="anchor" aria-label="anchor" href="#arg-n"></a></dt>
<dd><p>constraint on the total expected sample size of the program, default: <code>Inf</code>, e.g. no constraint</p></dd>


<dt id="arg-s">S<a class="anchor" aria-label="anchor" href="#arg-s"></a></dt>
<dd><p>constraint on the expected probability of a successful program, default: <code>-Inf</code>, e.g. no constraint</p></dd>


<dt id="arg-steps-">steps1<a class="anchor" aria-label="anchor" href="#arg-steps-"></a></dt>
<dd><p>lower boundary for effect size category "small" in RR scale, default: 1</p></dd>


<dt id="arg-stepm-">stepm1<a class="anchor" aria-label="anchor" href="#arg-stepm-"></a></dt>
<dd><p>lower boundary for effect size category "medium" in RR scale = upper boundary for effect size category "small" in RR scale, default: 0.95</p></dd>


<dt id="arg-stepl-">stepl1<a class="anchor" aria-label="anchor" href="#arg-stepl-"></a></dt>
<dd><p>lower boundary for effect size category "large" in RR scale = upper boundary for effect size category "medium" in RR scale, default: 0.85</p></dd>


<dt id="arg-b-">b1<a class="anchor" aria-label="anchor" href="#arg-b-"></a></dt>
<dd><p>expected gain for effect size category "small"</p></dd>


<dt id="arg-b-">b2<a class="anchor" aria-label="anchor" href="#arg-b-"></a></dt>
<dd><p>expected gain for effect size category "medium"</p></dd>


<dt id="arg-b-">b3<a class="anchor" aria-label="anchor" href="#arg-b-"></a></dt>
<dd><p>expected gain for effect size category "large"</p></dd>


<dt id="arg-strategy">strategy<a class="anchor" aria-label="anchor" href="#arg-strategy"></a></dt>
<dd><p>choose strategy: 1 (only the best promising candidate), 2 (all promising candidates) or 3 (both strategies)</p></dd>


<dt id="arg-num-cl">num_cl<a class="anchor" aria-label="anchor" href="#arg-num-cl"></a></dt>
<dd><p>number of clusters used for parallel computing, default: 1</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>The output of the function is a <code>data.frame</code> object containing the optimization results:</p><dl><dt>u</dt>
<dd><p>maximal expected utility under the optimization constraints, i.e. the expected utility of the optimal sample size and threshold value</p></dd>
<dt>RRgo</dt>
<dd><p>optimal threshold value for the decision rule to go to phase III</p></dd>
<dt>n2</dt>
<dd><p>total sample size for phase II; rounded to the next even natural number</p></dd>

<dt>n3</dt>
<dd><p>total sample size for phase III; rounded to the next even natural number</p></dd>

<dt>n</dt>
<dd><p>total sample size in the program; n = n2 + n3</p></dd>

<dt>K</dt>
<dd><p>maximal costs of the program (i.e. the cost constraint, if it is set or the sum K2+K3 if no cost constraint is set)</p></dd>

<dt>pgo</dt>
<dd><p>probability to go to phase III</p></dd>

<dt>sProg</dt>
<dd><p>probability of a successful program</p></dd>
<dt>sProg2</dt>
<dd><p>probability of a successful program with two arms in phase III</p></dd>

<dt>sProg3</dt>
<dd><p>probability of a successful program with three arms in phase III</p></dd>
<dt>K2</dt>
<dd><p>expected costs for phase II</p></dd>

<dt>K3</dt>
<dd><p>expected costs for phase III</p></dd>

</dl><p>and further input parameters. Taking <code>cat(comment())</code> of the
data frame lists the used optimization sequences, start and
finish time of the optimization procedure. The attribute
<code>attr(,"trace")</code> returns the utility values of all parameter
combinations visited during optimization.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>IQWiG (2016). Allgemeine Methoden. Version 5.0, 10.07.2016, Technical Report. Available at <a href="https://www.iqwig.de/ueber-uns/methoden/methodenpapier/" class="external-link">https://www.iqwig.de/ueber-uns/methoden/methodenpapier/</a>, assessed last 15.05.19.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="co"># Activate progress bar (optional)</span></span></span>
<span class="r-in"><span><span class="kw">if</span> <span class="op">(</span><span class="cn">FALSE</span><span class="op">)</span> <span class="fu">progressr</span><span class="fu">::</span><span class="fu"><a href="https://progressr.futureverse.org/reference/handlers.html" class="external-link">handlers</a></span><span class="op">(</span>global <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span> <span class="co"># \dontrun{}</span></span></span>
<span class="r-in"><span><span class="co"># Optimize</span></span></span>
<span class="r-in"><span><span class="co"># \donttest{</span></span></span>
<span class="r-in"><span><span class="fu">optimal_multiarm_binary</span><span class="op">(</span> p0 <span class="op">=</span> <span class="fl">0.6</span>, </span></span>
<span class="r-in"><span>  p11 <span class="op">=</span>  <span class="fl">0.3</span>, p12 <span class="op">=</span> <span class="fl">0.5</span>, </span></span>
<span class="r-in"><span>  n2min <span class="op">=</span> <span class="fl">20</span>, n2max <span class="op">=</span> <span class="fl">100</span>, stepn2 <span class="op">=</span> <span class="fl">4</span>,               <span class="co"># define optimization set for n2</span></span></span>
<span class="r-in"><span>  rrgomin <span class="op">=</span> <span class="fl">0.7</span>, rrgomax <span class="op">=</span> <span class="fl">0.9</span>, steprrgo <span class="op">=</span> <span class="fl">0.05</span>,     <span class="co"># define optimization set for RRgo</span></span></span>
<span class="r-in"><span>  alpha <span class="op">=</span> <span class="fl">0.025</span>, beta <span class="op">=</span> <span class="fl">0.1</span>,                         <span class="co"># drug development planning parameters</span></span></span>
<span class="r-in"><span>  c2 <span class="op">=</span> <span class="fl">0.75</span>, c3 <span class="op">=</span> <span class="fl">1</span>, c02 <span class="op">=</span> <span class="fl">100</span>, c03 <span class="op">=</span> <span class="fl">150</span>,           <span class="co"># fixed/variable costs for phase II/III</span></span></span>
<span class="r-in"><span>  K <span class="op">=</span> <span class="cn">Inf</span>, N <span class="op">=</span> <span class="cn">Inf</span>, S <span class="op">=</span> <span class="op">-</span><span class="cn">Inf</span>,                        <span class="co"># set constraints</span></span></span>
<span class="r-in"><span>  steps1 <span class="op">=</span> <span class="fl">1</span>,                                        <span class="co"># define lower boundary for "small"</span></span></span>
<span class="r-in"><span>  stepm1 <span class="op">=</span> <span class="fl">0.95</span>,                                     <span class="co"># "medium"</span></span></span>
<span class="r-in"><span>  stepl1 <span class="op">=</span> <span class="fl">0.85</span>,                                     <span class="co"># and "large" effect size categories</span></span></span>
<span class="r-in"><span>  b1 <span class="op">=</span> <span class="fl">1000</span>, b2 <span class="op">=</span> <span class="fl">2000</span>, b3 <span class="op">=</span> <span class="fl">3000</span>,                   <span class="co"># define expected benefits </span></span></span>
<span class="r-in"><span>  strategy <span class="op">=</span> <span class="fl">1</span>, num_cl <span class="op">=</span> <span class="fl">1</span><span class="op">)</span>                          <span class="co"># number of cores for parallelized computing </span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Optimization result:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Utility: 1562.11</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Sample size:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    phase II: 100, phase III: 193, total: 293</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Probability to go to phase III: 0.97</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Total cost:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    phase II: 175, phase III: 338, cost constraint: Inf</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Fixed cost:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    phase II: 100, phase III: 150</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Variable cost per patient:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    phase II: 0.75, phase III: 1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Effect size categories (expected gains):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   small: 1 (1000), medium: 0.95 (2000), large: 0.85 (3000)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Success probability: 0.76</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Success probability for a trial with:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    two arms in phase III: 0.76, three arms in phase III: 0</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Significance level: 0.025</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Targeted power: 0.9</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Decision rule threshold: 0.85 [RRgo] </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Assumed true rates: </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    control group: 0.6,  treatment 1: 0.3, treatment 2: 0.5</span>
<span class="r-in"><span>  <span class="co"># }</span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Stella Erdmann, Johannes Cepicka, Marietta Kirchner, Meinhard Kieser, Lukas D. Sauer.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

    </footer></div>





  </body></html>

